Randomized phase II study of interleukin-12 in combination with rituximab in patients with non-Hodgkin's lymphoma

Trial Profile

Randomized phase II study of interleukin-12 in combination with rituximab in patients with non-Hodgkin's lymphoma

Completed
Phase of Trial: Phase II

Latest Information Update: 23 Aug 2013

At a glance

  • Drugs Interleukin-12 (Primary) ; Rituximab (Primary)
  • Indications Chronic lymphocytic leukaemia; Follicular lymphoma; Mantle-cell lymphoma; Marginal-zone-B-cell-lymphoma; Non-Hodgkin's lymphoma; Waldenstrom's macroglobulinaemia
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 Dec 2012 Primary endpoints added as reported by ClinicalTrials.gov.
    • 08 Mar 2008 Status changed from in progress to completed.
    • 06 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top